KIMBRIX THERAPEUTICS
Dead / Abandoned — Abandoned — no statement of use filed (as of 09 Dec 2024)
What this means for you
This application is over — abandoned 09 Dec 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97901770
- Mark type
- Stylized text
- Filed
- 21 Apr 2023
- Published for opposition
- 12 Mar 2024
- Abandoned
- 09 Dec 2024
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of cancer and immune-related diseases and disorders; pharmaceutical preparations for treating oncological disorders and diseases and immune-related diseases and disorders
Owner
- MEI Pharma Inc., San Diego, CA, US
- MEI Pharma Inc., San Diego, CA, US
Prosecution history
- 09 Dec 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 09 Dec 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 07 May 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Mar 2024 — PUBLISHED FOR OPPOSITION
- 21 Feb 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Feb 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Feb 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Feb 2024 — EXAMINER'S AMENDMENT ENTERED
- 02 Feb 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 02 Feb 2024 — EXAMINERS AMENDMENT E-MAILED
- 02 Feb 2024 — EXAMINERS AMENDMENT -WRITTEN
- 18 Jan 2024 — ASSIGNED TO EXAMINER
- 18 May 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 25 Apr 2023 — NEW APPLICATION ENTERED